Literature DB >> 15302678

Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.

Csaba Lengyel1, László Dézsi, Péter Biliczki, Csilla Horváth, László Virág, Norbert Iost, Miklós Németh, László Tálosi, Julius Gy Papp, András Varró.   

Abstract

1. The aim of this study was to analyse the effects of eliprodil, a noncardiac drug with neuroprotective properties, on the cardiac repolarisation under in vitro circumstances, under normal conditions and after the attenuation of the 'repolarisation reserve' by blocking the inward rectifier potassium current (I(K1)) current with BaCl(2). 2. In canine right ventricular papillary muscle by applying the conventional microelectrode technique, under normal conditions, eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9). 3. This effect was augmented in preparations where I(K1) was previously blocked by BaCl(2) (10 microm). BaCl(2) alone lengthened APD in a reverse frequency-dependent manner (7.0+/-1.3, 14.2+/-1.6 and 28.1+/-2.1% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=8). When eliprodil (1 microm) was administered to these preparations, the drug induced a marked further lengthening relative to the APD values measured after the administration of BaCl(2) (12.5+/-1.0, 17.6+/-1.5 and 20.5+/-0.9% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=8). 4. In the normal Langendorff-perfused rabbit heart, eliprodil (1 microm) produced a significant QT(c) prolongation at 1 Hz stimulation frequency (12.7+/-1.8%, n=9). After the attenuation of the 'repolarisation reserve' by the I(K1) blocker BaCl(2) (10 microm), the eliprodil-evoked QT(c) prolongation was greatly enhanced (28.5+/-7.9%, n=6). In two out of six Langendorff preparations, this QT(c) lengthening degenerated into torsade de pointes ventricular tachycardia. 5. Eliprodil significantly decreased the amplitude of rapid component of the delayed rectifier potassium current (I(Kr)), but slow component (I(Ks)), transient outward current (I(to)) and I(K1) were not considerably affected by the drug when measured in dog ventricular myocytes by applying the whole-cell configuration of the patch-clamp technique. 6. The results indicate that eliprodil, under normal conditions, moderately lengthens cardiac repolarisation by inhibition of I(Kr). However, after the attenuation of the normal 'repolarisation reserve', this drug can induce marked QT interval prolongation, which may result in proarrhythmic action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302678      PMCID: PMC1575264          DOI: 10.1038/sj.bjp.0705901

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  The long QT syndrome.

Authors:  S G Priori; R Bloise; L Crotti
Journal:  Europace       Date:  2001-01       Impact factor: 5.214

Review 2.  Electrophysiological remodeling in hypertrophy and heart failure.

Authors:  G F Tomaselli; E Marbán
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

Review 3.  NMDA receptor antagonists as analgesics: focus on the NR2B subtype.

Authors:  B A Chizh; P M Headley; T M Tzschentke
Journal:  Trends Pharmacol Sci       Date:  2001-12       Impact factor: 14.819

4.  The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.

Authors:  A Varro; B Baláti; N Iost; J Takács; L Virág; D A Lathrop; L Csaba; L Tálosi; J G Papp
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

Review 5.  QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.

Authors:  F De Ponti; E Poluzzi; N Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2000-04       Impact factor: 2.953

6.  The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.

Authors:  G A Gintant; J T Limberis; J S McDermott; C D Wegner; B F Cox
Journal:  J Cardiovasc Pharmacol       Date:  2001-05       Impact factor: 3.105

Review 7.  Cardiac K+ channels and drug-acquired long QT syndrome.

Authors:  M D Drici; J Barhanin
Journal:  Therapie       Date:  2000 Jan-Feb       Impact factor: 2.070

8.  Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea-pig cardiomyocytes.

Authors:  G X Liu; C Derst; G Schlichthörl; S Heinen; G Seebohm; A Brüggemann; W Kummer; R W Veh; J Daut; R Preisig-Müller
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

9.  Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1.

Authors:  H Swan; K Saarinen; K Kontula; L Toivonen; M Viitasalo
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

Review 10.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  8 in total

1.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.

Authors:  Akira Takahara; Atsushi Sugiyama; Keitaro Hashimoto
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Gender differences in the slow delayed (IKs) but not in inward (IK1) rectifier K+ currents of canine Purkinje fibre cardiac action potential: key roles for IKs, beta-adrenoceptor stimulation, pacing rate and gender.

Authors:  Najah Abi-Gerges; Ben G Small; Chris L Lawrence; Tim G Hammond; Jean-Pierre Valentin; Chris E Pollard
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 5.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

Review 6.  The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Authors:  Ana I Lopez-Medina; Choudhary Anwar A Chahal; Jasmine A Luzum
Journal:  Pharmacogenomics       Date:  2022-06-14       Impact factor: 2.638

Review 7.  A structural biology perspective on NMDA receptor pharmacology and function.

Authors:  Michael C Regan; Annabel Romero-Hernandez; Hiro Furukawa
Journal:  Curr Opin Struct Biol       Date:  2015-08-15       Impact factor: 6.809

8.  Evaluation of 11C-NR2B-SMe and Its Enantiomers as PET Radioligands for Imaging the NR2B Subunit Within the NMDA Receptor Complex in Rats.

Authors:  Lisheng Cai; Jeih-San Liow; Cheryl L Morse; Sanjay Telu; Riley Davies; Michael P Frankland; Sami S Zoghbi; Ken Cheng; Matthew D Hall; Robert B Innis; Victor W Pike
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.